ViaDerma Inc (VDRM)

[whatarush12]

ViaDerma = $$'s coming this year! Here's all the DD you need to know.

March 8, 2017
~ Sales, labeling & marketing being launched!! Industry expert hired!! ~
http://www.marketwired.com/press-release/viaderma-inc-hires-product-rollout-expert-manage-quality-control-labeling-marketing-pinksheets-vdrm-2201662.htm

~Ivan Klarich Reviews~
https://www.linkedin.com/in/ivanklarich/
Aidan Roark Makepeace
Founder/CEO at WRKPRTY
Aidan Roark worked with Ivan in different groups
I have had the privilege of working with and for Ivan on several software development and business strategy projects ranging from the start-up to the enterprise level and can say, without reservation, Ivan is amazing to work with. Ivan is a thoughtful and inspiring leader and team-builder, and an energetic, diligent, and reliable visionary in strategic planning and operations/executive management. I welcome every opportunity to work with Ivan and can wholeheartedly recommend his services, as well as those of his extensive team of associates.
Mireille Buiel
HR Lead at FindHotel
Mireille worked with Ivan but at different companies
I have worked together with Ivan as consultants at a California based FMCG manufacturing company. I got to know him as a value-based strategic thinker that keeps his eye on the long-term goal. He is able to bring teams and entrepreneurs quickly to the ‘pain points’ and find new practical solutions for their business (model) issues. I would definitely recommend him for complex organizational and commercial challenges.
John Fanaris
Co-Owner/GM/Sommelier at Rustic Kitchen
John worked with Ivan but at different companies
Preparing for growth and putting the right pieces together are crucial to success and Ivan brings the tools needed to the table. He has a non-confrontational demeanor in his analysis of your internal methodology with the uncanny knack of straight forward communication and a tell-it-like-it-is constructive advice. He is an expert at analyzing company operations and culture to develop a comprehensive strategy to reach your goals. If you are looking to take your company to the next level, Ivan is your man.
Jackie Lapin / Authors, Speakers, Get Leads, Get Booked
?? AUTHORS & SPEAKERS, GET LEADS, GET BOOKED–Book Your Own Speaking Engagements at Transformational Venues & Events
Jackie Lapin / worked with Ivan but at different companies
Ivan is one of the most brilliant forward-thinking business visionaries I've ever encountered. That skill is anchored by real world practical strategic analytics and implementation that ensures success. I want him on my team whenever I'm launching something new, improve what's already working or need to fix something that's not!

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129418493
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129409088
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129402020
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129401494
http://www.hopedance.org/home/awakenings/2920-virtual-realty-enters-the-arena-to-help-people-overcome-their-co-dependency-on-outside-approval-to-achieve-an-emotionally-free-high-performance-happy-life
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129344707
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129339497


February 15, 2017
~ Additional patents are being filed in the MMJ space! ~
http://www.marketwired.com/press-release/viaderma-inc-looks-file-additional-patents-license-new-products-its-mmj-medical-marijuana-otc-pink-vdrm-2196107.htm

http://www.thedailychronic.net/2017/68842/clinical-trial-thcv-lowers-blood-sugar-levels-in-type-2-diabetics/
http://www.thedailychronic.net/2017/69698/study-medical-cannabis-patients-reduce-their-use-of-opioids/
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129340717
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129277006
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129022846
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129017714


February 8, 2017
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 21-23, 2017 ~
http://www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm

https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129403043
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129390203
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129368069
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129334996
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129312100
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129311752
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129297007
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129296364
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129295215
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129286262
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129196331
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129040891
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128962099
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128961948
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128957163


February 3, 2017
~ MASSIVE sales coming.. 500,000 units x $125 = $62,500,000 in 2017~
http://www.marketwired.com/press-release/viaderma-inc-targets-online-sales-wound-care-centers-distribution-companies-its-viabecline-pinksheets-vdrm-2193323.htm

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129402236
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129339194
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129286070


January 11, 2017
~Filed a patent application with the USPTO for its proprietary innovative transdermal delivery system~
http://www.marketwired.com/press-release/viaderma-incs-ceo-files-new-patent-application-signs-two-licensing-deals-locates-product-otc-pink-vdrm-2187878.htm

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129386093
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129283860


November 30, 2016
"Patent Pending Transdermal System" can deliver medications and nutrients into the body through the skin. The solution combined with FDA registered drugs can increase the absorption as much as 100 times directly to the localized treatment areas,
http://www.marketwired.com/press-release/viaderma-inc-clinical-studies-abroad-europe-middle-east-asia-show-promising-results-otc-pink-vdrm-2179850.htm


November 14, 2016
Filed Patent Pending use of its innovative transdermal system for the delivery of (CBD's) Calanoids and (THC) Tetrahydrocannabinol for the treatment of several diseases
http://www.marketwired.com/press-release/viaderma-inc-enters-mmj-medical-marijuana-industry-with-patent-pending-cbd-delivery-otc-pink-vdrm-2175498.htm


Current Market Cap ~ $9.5mill, March 10, 2017~

Share Structure
Authorized Shares 400,000,000 a/o Mar 07, 2017
Outstanding Shares 321,232,603 a/o Mar 07, 2017
-Restricted 57,975,478 a/o Mar 07, 2017
-Unrestricted 263,257,125 a/o Mar 07, 2017
Held at DTC 246,331,609 a/o Mar 07, 2017
Float 222,337,825 a/o Jan 25, 2017


2dollarbill ~ REPOST
just doing my part here...

Lead Product TetraStem
World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results. Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.
Very low water content and optimum (low) viscosity. Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile.

Potential Markets
ViaDerma is developing products in many fields of use, including:
Topical antibiotics- $6 billion/year
Toenail antifungal drugs- $3 billion/year
Diabetic amputations- $3 billion/year
Global acne- $3.02 billion/year
Psoriasis- $7.3 billion/year
Eczema- $2.5 billion/year

Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. Innovative, patent pending dual carrier transdermal technology which can transform oral medication into topical products. Ability to enable active ingredients with a rapid transport direct to the site of action.

Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis. Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life. Facilitates transfer of chemicals through the stratum corneum with a diffusion constant 10,000x higher. Strong Advanced Biological Coverage (ABC) which has higher concentrations, faster penetration and is more effective than conventional antibiotics. ABC produces desirable results in ~24 hours or less compared to 5-7 days. It kills all harmful gram-positive and gram-negative bacteria that have been available for testing.

1- back in 2.25.2014 philips manufactured there last fda approval of tetrastem, its a 3 year shelf life as im able to see
2 - in 5.28.2014 VDRM started to manufacture there first fda approval of tetrastem, same 3 year shelf life
3 - now heres where it make huge sense in 3.2014 VDRM gets the rights to manufacture tetrastem from phlips....1 month after they start there first manufacture of tetrastem
4 - the 3 - 6 - 9 month studies kick in in a huge way, and now VDRM as of 1.2017 manufactures 500,000 bottles for sale,
...basically they took what worked expanded on it and said this is huger than we thought
5 - 12.2016 VDRM files for uopdated Viabecline patent - which is purely application - so that means anyone, anywhere, anytime they use tetrastem - pure play on licensing application
6 - back in 2015 rumors started that both PFE and MRK and Endo pharma were looking at VDRM
7 - 2.2017 Dr Otiko to write a paper on diabetic ulcers showing massive results - which means all roads to viabecline

articles of interest ( get them off the web )
1 - from a 2.2011 study reposted in 1.2017 paraplegic uses tetrastem with stem cells and walks again ( philips put the article out )
2 - 3.2015 onychmycosis article
3 - 11.2016 viabecline article
4 - 12.2016 diabetic ulcers study vdrm issued
5 - 12.2016 viabecline patent applied for
6 - 1.2017 vdrm 500,000 bottles manufactured for 2017 grossing 62-65M in sales

viabecline is a delivery of tetrastem - which can take any oral as well and apply to ointment application

PFE is all about viagra, now imagine a lotion for f on f , not just a pill, and youve opened a huge market in the world away of same sex...mrk is all about diabetes and with application wise they want in too, add in JNJ which bandaids work and graduate to a 1000% increase in healing and they want in too...

VDRM product is 85% cheaper and works better - Viabecline is what the entire game is all about here - application technology

PFE Viagra is a category killer but it is a pill - and a pill is a introduction internally to the blood stream which out of fear a great portion of the population will just not take, now factor in a female Viagra alternative that is topical and replace the male Viagra with the same topical and its obvious that PFE will be forced to enter some sort of licensing agreement to hold onto there market share and as well look to capitalize on the female market as well ( m on f , and f on f ) there are those that will only use topical not internal

MRK, LLY and MNKD are the diabetic market and its huge - toenail fungal market - now add on a turnaround solution they have been needing for years, to treat at home foot infections ( home care largest market globally ) and that market alone is extraordinary with multiple companies all vying to be the dominant player and VDRM having the solution to license

JNJ marketplace is wounds - the band , now graduate it to the ability to speed the process up say 10 fold to heal any scrapes scratched wounds and to hold there market-share JNJ will be forced to enter some sort of licensing deal just to hold the line or risk crippling there empire quite easily

MRK and JNJ baldness market is in a level all itself, as its a do it yourself world we live in - add a just for men/ ladies crowd solution to expand into the baldness market and make that a CVS Walgreen's etc play for direct access more licensing

without even touching on the other markets there is exceptional growth here

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


~Info on Dr. Chris Otiko, CEO of ViaDerma~

Radio interview from December 9, 2016. https://upticknewswire.com/viaderma-ceo-dr-chris-otiko-talks-active-treatments-for-diabetic-wounds/
https://www.linkedin.com/in/chris-ayo-otiko-80284b5/
https://www.linkedin.com/pulse/healing-diabetic-ulcers-viabecline-new-topical-antibiotic-otiko
https://www.barbadostoday.bb/2014/07/05/miracle-drug-for-diabetics/
http://www.neurogenx.com/testimonial/christopher-otiko-dpm-ceo-executive-medical-director/
https://www.ratemds.com/doctor-ratings/2334438/Dr-Christopher+A.-Otiko-Reseda-CA.html
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129394138
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129356678
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129353170
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129346970
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129340283
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129311397
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129294386
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129283754
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129265204
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129223612
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129222563


~Patent/Licensing/Manufacturing Info~
https://www.drugs.com/otc/129916/tetrastem.html
(licensed as Diabecline and Viabecline). Regardless of who owns or has the rights to the patent, ViaDerma has licensing rights, and has filed a new patent pending application for the transdermal system as per January 11, 2017 PR
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129289616
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129282983
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129282283
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129280927
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129279832
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129273942
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129273861
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129234169
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129232328
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129224588
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129224450
investorshub.advfn.com/boards/read_msg.aspx?message_id=129224065


Interesting posts!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129413941
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129397880
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129394039
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129392467
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129386665
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129383996
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129357204
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129351881
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129346142
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129334810
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129329694
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129308249
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129278022
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129268497
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129200839
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129127030
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129126891
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129022830
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129011372


GLTA

LONG $VDRM